Cargando…

COVID-19 mRNA vaccination is associated with IgA nephropathy: an analysis of the Japanese adverse drug event report database

Purpose: Coronavirus disease 2019 (COVID-19) mRNA vaccines are used worldwide to prevent severe symptoms of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. IgA nephropathy (IgAN) is the most common form of glomerular injury after COVID-19 vaccination; however, because of the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nakao, Hiroka, Koseki, Takenao, Kato, Koki, Yamada, Shigeki, Tsuboi, Naotake, Takahashi, Kazuo, Mizuno, Tomohiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Science archive
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10348063/ https://www.ncbi.nlm.nih.gov/pubmed/37456806 http://dx.doi.org/10.3389/jpps.2023.11453

Ejemplares similares

Frequency of Immune Checkpoint Inhibitor-Induced Vasculitides: An Observational Study Using Data From the Japanese Adverse Drug Event Report Database
por: Kato, Koki, et al.
Publicado: (2022)

Occurrence of intraocular hemorrhages under monotherapy or combination therapy of antiplatelets and anticoagulants using the Japanese Adverse Drug Event Report database
por: Tanaka, Junko, et al.
Publicado: (2023)

Enteric Budesonide in Transplant and Native IgA Nephropathy: Real-World Clinical Practice
por: Lopez-Martinez, Marina, et al.
Publicado: (2022)

Pregnancy Complications and Impact on Kidney Allograft After Kidney Transplantation in IgA Nephropathy
por: Oki, Rikako, et al.
Publicado: (2023)

Prediction model of acute kidney injury induced by cisplatin in older adults using a machine learning algorithm
por: Okawa, Takaya, et al.
Publicado: (2022)

Corrigendum: Enteric Budesonide in Transplant and Native IgA Nephropathy: Real-World Clinical Practice
por: Lopez-Martinez, Marina, et al.
Publicado: (2023)

Racial heterogeneity of IgA1 hinge-region O-glycoforms in patients with IgA nephropathy
por: Ohyama, Yukako, et al.
Publicado: (2022)

Seasonal proteinuria changes in IgA nephropathy patients after proteinuria remission
por: Inagaki, Koji, et al.
Publicado: (2017)

Baseline uric acid levels and steady-state favipiravir concentrations are associated with occurrence of hyperuricemia among COVID-19 patients
por: Koseki, Takenao, et al.
Publicado: (2022)

Clinical impact of endocapillary proliferation with modified cutoff points in IgA nephropathy patients
por: Kaihan, Ahmad Baseer, et al.
Publicado: (2019)

Analysis of O-glycoforms of the IgA1 hinge region by sequential deglycosylation
por: Ohyama, Yukako, et al.
Publicado: (2020)

mrna-1273: IgA nephropathy and IgA vasculitis flairs : 4 case reports
Publicado: (2021)

A pharmacovigilance approach for assessing the occurrence of suicide-related events induced by antiepileptic drugs using the Japanese adverse drug event report database
por: Koseki, Takenao, et al.
Publicado: (2023)

Author Correction: Analysis of O-glycoforms of the IgA1 hinge region by sequential deglycosylation
por: Ohyama, Yukako, et al.
Publicado: (2021)

Improved renal survival in Japanese children with IgA nephropathy
por: Yata, Nahoko, et al.
Publicado: (2008)

IgA nephropathy with glomerular capillary IgA deposition following SARS-CoV-2 mRNA vaccination: a report of three cases
por: Yokote, Shinya, et al.
Publicado: (2022)

The Role of IgA in the Pathogenesis of IgA Nephropathy
por: Perše, Martina, et al.
Publicado: (2019)

IgA Nephropathy with Gross Hematuria Following COVID-19 mRNA Vaccination
por: Nihei, Yoshihito, et al.
Publicado: (2022)

Tonsillectomy Monotherapy for IgA Nephropathy: A Case Series
por: Marumoto, Hirokazu, et al.
Publicado: (2020)

IgA Vasculitis and IgA Nephropathy: Same Disease?
por: Pillebout, Evangeline
Publicado: (2021)

mRNA-1273: IgA nephropathy flare: case report
Publicado: (2021)

Experimental IgA nephropathy
Publicado: (1979)

Sulodexide in IgA nephropathy
Publicado: (2013)

T lymphocytes in IgA nephropathy
por: Tang, Yuyan, et al.
Publicado: (2020)

Secondary IgA Nephropathy Shares the Same Immune Features With Primary IgA Nephropathy
por: Wang, Manliu, et al.
Publicado: (2019)

Validation of the International IgA Nephropathy Prediction Tool in the Greek Registry of IgA Nephropathy
por: Papasotiriou, Marios, et al.
Publicado: (2022)

Enzymatic Sialylation of IgA1 O-Glycans: Implications for Studies of IgA Nephropathy
por: Takahashi, Kazuo, et al.
Publicado: (2014)

Current understanding of IgA antibodies in the pathogenesis of IgA nephropathy
por: Nihei, Yoshihito, et al.
Publicado: (2023)

Renal expression of trefoil factor 3 mRNA in association with tubulointerstitial fibrosis in IgA nephropathy
por: Tanaka, Keiko, et al.
Publicado: (2018)

Mucosal Immune System Dysregulation in the Pathogenesis of IgA Nephropathy
por: Kano, Toshiki, et al.
Publicado: (2022)

Clinical significance of serum and mesangial galactose-deficient IgA1 in patients with IgA nephropathy
por: Wada, Yukihiro, et al.
Publicado: (2018)

IgA Nephropathy Genetic Risk Score to Estimate the Prevalence of IgA Nephropathy in UK Biobank
por: Sukcharoen, Kittiya, et al.
Publicado: (2020)

Secondary IgA Nephropathy and IgA-Associated Nephropathy: A Systematic Review of Case Reports
por: Tota, Maciej, et al.
Publicado: (2023)

Aberrantly Glycosylated IgA1 in IgA Nephropathy: What We Know and What We Don’t Know
por: Ohyama, Yukako, et al.
Publicado: (2021)

Predictors of Gross Hematuria After SARS-CoV-2 mRNA Vaccination in Patients with IgA Nephropathy
por: Yokote, Shinya, et al.
Publicado: (2023)

Galactose-Deficient IgA1 as a Candidate Urinary Marker of IgA Nephropathy
por: Fukao, Yusuke, et al.
Publicado: (2022)

mRNA-1273: IgA nephropathy flare-up: case report
Publicado: (2021)

Thrombotic Microangiopathy in IgA Nephropathy
por: Nasri, Hamid
Publicado: (2013)

Role of complement in IgA nephropathy
por: Daha, Mohamed R., et al.
Publicado: (2015)

Nutcracker phenomenon in IgA nephropathy
por: Imai, Naohiko, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_guvis0pn53hnbgs8cdk509po8n